Abstract
Parkinson disease is one of the most common human neurodegenerative diseases. Its importance has led to a large number of studies focused on the development of cellular and animal models for the disease. We first discuss the potentials and limitations of the available mammalian models for PD. The results obtained so far in some alternative models, such as yeasts or invertebrates (Drosophila, Caenorhabditis), that may be used to develop rapid genetic or pharmacological screenings, are also summarized. Finally, we briefly discuss the results derived from novel approaches, such as the analysis of expression profiles using microarrays and proteomic analyses of cellular and animal models of Parkinson disease. Integration of the data derived from all those approaches emerges as a significant problem to be solved in the next few years.
Keywords: parkinson disease, mouse, yeast, caenorhabditis, drosophila, microarrays, proteomics
Current Genomics
Title: Parkinson Disease: From Cellular and Animal Models to Genomics
Volume: 6 Issue: 4
Author(s): Ignacio Marin and Jorge Vallejo
Affiliation:
Keywords: parkinson disease, mouse, yeast, caenorhabditis, drosophila, microarrays, proteomics
Abstract: Parkinson disease is one of the most common human neurodegenerative diseases. Its importance has led to a large number of studies focused on the development of cellular and animal models for the disease. We first discuss the potentials and limitations of the available mammalian models for PD. The results obtained so far in some alternative models, such as yeasts or invertebrates (Drosophila, Caenorhabditis), that may be used to develop rapid genetic or pharmacological screenings, are also summarized. Finally, we briefly discuss the results derived from novel approaches, such as the analysis of expression profiles using microarrays and proteomic analyses of cellular and animal models of Parkinson disease. Integration of the data derived from all those approaches emerges as a significant problem to be solved in the next few years.
Export Options
About this article
Cite this article as:
Marin Ignacio and Vallejo Jorge, Parkinson Disease: From Cellular and Animal Models to Genomics, Current Genomics 2005; 6 (4) . https://dx.doi.org/10.2174/1389202054395955
DOI https://dx.doi.org/10.2174/1389202054395955 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bee Pollen: Chemical Composition and Potential Beneficial Effects on Health
Current Nutrition & Food Science A Critical Evaluation of Adenosine A2A Receptors as Potentially “Druggable” Targets in Huntingtons Disease
Current Pharmaceutical Design Development of Prolactin Receptor Antagonists: Same Goal, Different Ways
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Contribution of ALDH2 Polymorphism to Alcoholism-Associated Hypertension
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Oral Fast-Release Solid Dispersion-Paradigm Shift to Nanoparticles
Recent Patents on Drug Delivery & Formulation Presenilin and γ -Secretase Activity: A Viable Therapeutic Target for Alzheimers Disease?
Current Signal Transduction Therapy <i>Nigella sativa</i> L., Supplementary Plant with Anticholinesterase Effect for Cognition Problems: A Kinetic Study
Current Aging Science Heme Oxygenase-1 in Tumor Biology and Therapy
Current Drug Targets Prospective Role of Polyphenolic Compounds in the Treatment of Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets A Potential Role of the Curry Spice Curcumin in Alzheimers Disease
Current Alzheimer Research Pharmacokinetics of Selegiline in a Rabbit Model
Letters in Drug Design & Discovery Synthesis of New Peptide Derivatives of Galanthamine Designed for Prevention and Treatment of Alzheimer’s Disease
Protein & Peptide Letters Meet Our Section Editor
Current Medicinal Chemistry Meet Our Editorial Board Member:
Current Medicinal Chemistry Artificial Neural Network (ANN) Based Modelling for D1 Like and D2 Like Dopamine Receptor Affinity and Selectivity
Medicinal Chemistry Editorial [ Hot Topic:Reproductive Issues for Women with Sclizophrenia(Guest Editors: Mary V. Seeman and Laura J. Miller) ]
Current Women`s Health Reviews Pharmacotherapy for Bipolar Depression: A Review of the Evidence
Current Psychiatry Reviews A Brief Overview of Tyrosine Hydroxylase and α-Synuclein in the Parkinsonian Brain
CNS & Neurological Disorders - Drug Targets Molecular Hydrogen: New Antioxidant and Anti-inflammatory Therapy for Rheumatoid Arthritis and Related Diseases
Current Pharmaceutical Design Osteoclast Apoptosis in Rheumatic Diseases Characterized by a High Level of Bone Resorption (Osteoporosis, Rheumatoid Arthritis, Myeloma and Pagets Disease of Bone)
Current Rheumatology Reviews